Adaptive Biotechnologies Corp. (ADPT)
13.87
-0.09
(-0.64%)
USD |
NASDAQ |
May 21, 16:00
13.87
0.00 (0.00%)
After-Hours: 19:59
Adaptive Biotechnologies Research and Development Expense (TTM) : 83.21M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Thermo Fisher Scientific, Inc. | 1.391B |
| Sotera Health Co. | -- |
| FONAR Corp. | 1.771M |
| ICON plc | -- |
| Interpace Biosciences, Inc. | 0.618M |